Watson P - Search Results

1

Analysis of CHEK2 gene for ovarian cancer susceptibility.

Baysal BE, DeLoia JA, Willett-Brozick JE, Goodman MT, Brady MF, Modugno F, Lynch HT, Conley YP, Watson P, Gallion HH. Baysal BE, et al. Among authors: watson p. Gynecol Oncol. 2004 Oct;95(1):62-9. doi: 10.1016/j.ygyno.2004.07.015. Gynecol Oncol. 2004. PMID: 15385111

2

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT. Casey MJ, et al. Among authors: watson p. Gynecol Oncol. 2005 May;97(2):457-67. doi: 10.1016/j.ygyno.2005.01.039. Gynecol Oncol. 2005. PMID: 15863145

3

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P. Casey MJ, et al. Among authors: watson p. Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. doi: 10.1006/gyno.2000.5861. Gynecol Oncol. 2000. PMID: 10985881 Review.

4

Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.

Casey MJ, Bewtra C, Lynch HT, Snyder C, Stacy M, Watson P. Casey MJ, et al. Among authors: watson p. Fam Cancer. 2013 Dec;12(4):719-40. doi: 10.1007/s10689-013-9651-x. Fam Cancer. 2013. PMID: 23666231

5

Genetic counselling and hereditary breast ovarian cancer.

Lynch HT, Watson P. Lynch HT, et al. Among authors: watson p. Lancet. 1992 May 9;339(8802):1181. doi: 10.1016/0140-6736(92)90787-4. Lancet. 1992. PMID: 1349410 No abstract available.

6

The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.

Watson P, Bützow R, Lynch HT, Mecklin JP, Järvinen HJ, Vasen HF, Madlensky L, Fidalgo P, Bernstein I; International Collaborative Group on HNPCC. Watson P, et al. Gynecol Oncol. 2001 Aug;82(2):223-8. doi: 10.1006/gyno.2001.6279. Gynecol Oncol. 2001. PMID: 11531271

7

Cancer risk in mismatch repair gene mutation carriers.

Watson P, Lynch HT. Watson P, et al. Fam Cancer. 2001;1(1):57-60. doi: 10.1023/a:1011590617833. Fam Cancer. 2001. PMID: 14574017 Review.

8

BRCA1, pathology, and survival.

Lynch HT, Watson P. Lynch HT, et al. Among authors: watson p. J Clin Oncol. 1998 Feb;16(2):395-6. doi: 10.1200/JCO.1998.16.2.395. J Clin Oncol. 1998. PMID: 9469320 No abstract available.

9

Detecting BRCA2 protein truncation in tissue biopsies to identify breast cancers that arise in BRCA2 gene mutation carriers.

Watson P, Lieberman R, Snyder C, Clark VJ, Lynch HT, Holt JT. Watson P, et al. J Clin Oncol. 2009 Aug 20;27(24):3894-900. doi: 10.1200/JCO.2008.20.5211. Epub 2009 Jul 20. J Clin Oncol. 2009. PMID: 19620486 Free PMC article.

10

TGFBR1*6A may contribute to hereditary colorectal cancer.

Bian Y, Caldes T, Wijnen J, Franken P, Vasen H, Kaklamani V, Nafa K, Peterlongo P, Ellis N, Baron JA, Burn J, Moeslein G, Morrison PJ, Chen Y, Ahsan H, Watson P, Lynch HT, de la Chapelle A, Fodde R, Pasche B. Bian Y, et al. Among authors: watson p. J Clin Oncol. 2005 May 1;23(13):3074-8. doi: 10.1200/JCO.2005.00.281. J Clin Oncol. 2005. PMID: 15860866

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,485 results

Search Page

Filters